Page last updated: 2024-10-31

mianserin and Central Nervous System Origin Vertigo

mianserin has been researched along with Central Nervous System Origin Vertigo in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research Excerpts

ExcerptRelevanceReference
"Mirtazapine is a third-generation antidepressant with a dual mode of action."2.72Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients. ( Egger, C; Eichberger, G; Hinterhuber, H; Hofmann, P; Kasper, S; Konstantinidis, A; Mühlbacher, M; Nickel, M; Nimmerrichter, A; Schubert, H; Stuppaeck, C, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mühlbacher, M1
Konstantinidis, A1
Kasper, S1
Eichberger, G1
Hinterhuber, H1
Hofmann, P1
Nimmerrichter, A1
Schubert, H1
Egger, C1
Nickel, M1
Stuppaeck, C1

Trials

1 trial available for mianserin and Central Nervous System Origin Vertigo

ArticleYear
Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients.
    Neuropsychobiology, 2006, Volume: 53, Issue:2

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Fatigue; Fema

2006